Thus, while the cGAS–STING axis plays a pivotal role in mediating anti-tumor immunity when combining RT with PD-1/PD-L1 inhibitors, it also represents a potential driver of immunotoxicity in normal tissues. This evidence concerns the gene STING1 and neoplasm.